Boosted rat natural xenoantibodies cross-react with enterococcus faecalis by targeting melibiose and l-rhamnose

Journal of Innate Immunity

Volumn 6, Issue 2, 2014, Pages 140-151

  Perez Cruz, Magdiel ^a   Costa, Cristina ^a   Mañez, Rafael ^a,b  

^a Cancer Epigenetics and Biology Program   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Enterococcus faecalis; L Rhamnose; Melibiose; Natural antibody; Xenoantibody

Indexed keywords

ANTIBODY; GLYCAN; HETEROANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELIBIOSE; RHAMNOSE; UNCLASSIFIED DRUG; HETEROPHILE ANTIBODY; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CROSS REACTION; ENDOTHELIUM CELL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EXPERIMENTAL LIGATION; HUMAN; HUMAN CELL; IMMUNIZATION; LYMPHOCYTE; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PRIORITY JOURNAL; PUNCTURE; RAT; SEPSIS; SURVIVAL; T LYMPHOCYTE; ANIMAL; FLOW CYTOMETRY; HAMSTER; IMMUNOLOGY; LEWIS RAT; MESOCRICETUS; METABOLISM; MICROBIOLOGY; PIG; PROCEDURES;

ANIMALS; ANTIBODIES, HETEROPHILE; CRICETINAE; CROSS REACTIONS; ENDOTHELIAL CELLS; ENTEROCOCCUS FAECALIS; FLOW CYTOMETRY; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELIBIOSE; MESOCRICETUS; POLYSACCHARIDES; RATS, INBRED LEW; RHAMNOSE; SEPSIS; SURVIVAL ANALYSIS; SWINE; T-LYMPHOCYTES;

EID: 84896358991     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000355305     Document Type: Article

References (44)

1. Mond JJ, Lees A, Snapper CM: T cell-independentantigens type 2. Annu Rev Immunol1995; 13: 655-692.
2. Bouvet JP, Dighiero G: From natural polyreactiveautoantibodies to a la carte monoreactiveantibodies for infectious agents: is it asmall world after all? Infect Immun 1998; 66:1-4.
3. Cramer DV: Natural antibodies and the hostimmune responses to xenografts. Xenotransplantation2000; 7: 83-92. (Pubitemid 30603098)
4. Hammer C, Hingerle M: Development ofpreformed natural antibodies in gnotobioticdogs and pigs, impact of food antigens on antibodyspecificity. Transplant Proc 1992; 24:707-709.
5. Galili U, Anaraki F, Thall A, Hill-Black C,Radic M: One percent of human circulating Blymphocytes are capable of producing thenatural anti-Gal antibody. Blood 1993; 82:2485-2493. (Pubitemid 23304273)
6. Galili U, Mandrell RE, Hamadeh RM, ShohetSB, Griffiss JM: Interaction between humannatural anti-alpha-galactosyl immunoglobulinG and bacteria of the human flora. InfectImmun 1988; 56: 1730-1737.
7. Hamadeh RM, Jarvis GA, Galili U, MandrellRE, Zhou P, Griffiss JM: Human natural anti-Gal IgG regulates alternative complementpathway activation on bacterial surfaces. JClin Invest 1992; 89: 1223-1235.
8. Manez R, Blanco FJ, Diaz I, Centeno A, Lopez-Pelaez E, Hermida M, Davies HF, Katopodis A: Removal of bowel aerobic Gramnegativebacteria is more effective than immunosuppressionwith cyclophosphamideand steroids to decrease natural ?-galactosylIgG antibodies. Xenotrasplantation 2001; 8:15-23. (Pubitemid 32127071)
9. Parker W, Bruno D, Platt JL: Xenoreactivenatural antibodies in the world of natural antibodies:typical or unique? Transpl Immunol 1995; 3: 181-191.
10. Baquerizo A, Mhoyan A, Kearns-Jonker M,Arnaout WS, Shackleton C, Busuttil RW, Demetriou AA, Cramer DV: Characterizationof human xenoreactive antibodies in liverfailure patients exposed to pig hepatocytesafter bioartificial liver treatment: an ex vivomodel of pig to human xenotransplantation.Transplantation 1999; 67: 5-18. (Pubitemid 29061131)
11. Nozawa S, Xing PX, Wu GD, Gochi E,Kearns-Jonker M, Swensson J, Starnes VA,Sandrin MS, McKenzie IF, Cramer DV:Characteristics of immunoglobulin gene usageof the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockoutmouse. Transplantation 2001; 72: 147-155. (Pubitemid 32652521)
12. Cramer DV: Natural antibodies and the hostimmune responses to xenografts. Xenotransplantation 2000; 7: 83-92. (Pubitemid 30603098)
13. Kearns-Jonker M, Fraiman M, Chu W, GochiE, Michel J, Wu GD, Cramer DV: Xenoantibodiesto pig endothelium are expressed ingermline configuration and share a conservedimmunoglobulin VH gene structure with antibodiesto common infectious agents. Transplantation 1998; 65: 1515-1519. (Pubitemid 28285259)
14. Blixt O, Head S, Mondala T, Scanlan C, HuflejtME, Alvarez R, Bryan MC, Fazio F, CalareseD, Stevens J, Razi N, Stevens DJ, SkehelJJ, van Die I, Burton DR, Wilson IA, CummingsR, Bovin N, Wong CH, Paulson JC:Printed covalent glycan array for ligand profilingof diverse glycan binding proteins. ProcNatl Acad Sci USA 2004; 101: 17033-17038. (Pubitemid 39627769)
15. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31-36.
16. Bernatuil L, Kaye J, Rich RF, Fishman JA,Green WR, Iacomini J: The influence of naturalantibody specificity on antigen immunogenicity.Eur J Immunol 2005; 35: 2638-2647. (Pubitemid 41404047)
17. Yin D, Ma LL, Blinder L, Shen J, Sankary H, Williams JW, Chong AS: Induction of species-specific host accommodation in thehamster-to-rat xenotransplantation model. JImmunol 1998; 161: 2044-2051. (Pubitemid 28387631)
18. Ji P, Xia GL, Waer M: Absence of cross-reactivitybetween xenoantibodies directedagainst concordant or discordant xenoantigensin rats. Transplant Proc 2000; 32: 861. (Pubitemid 30601775)
19. Wei YQ, Wang QR, Zhao X, Yang L, Tian L,Kang B, Lu CJ, Huang MJ, Lou YY, Xiao F, HeQM, Shu JM, Xie XJ, Mao YQ, Lei S, Luo F,Zhou LQ, Liu CE, Zhou H, Jiang Y, Peng F,Yuan LP, Li Q, Wu Y, Liu JY: Immunotherapyof tumors with xenogeneic endothelial cells asa vaccine. Nat Med 2000; 6: 1160-1166.
20. Scappaticci FA, Contreras A, Boswell CA,Lewis JS, Nolan G: Polyclonal antibodies toxenogeneic endothelial cells induce apoptosisand block support of tumor growth in mice.Vaccine 2003; 21: 2667-2677. (Pubitemid 36561360)
21. Murray AM, Pearson IF, Fairbanks LD,Chalmers RA, Bain MD, Bax BE: The mouseimmune response to carrier erythrocyte entrappedantigens. Vaccine 2006; 24: 6129-6139. (Pubitemid 44175613)
22. Yamashita T, Kawashima S, Hirase T, ShinoharaM, Takaya T, Sasaki N, Takeda M, TawaH, Inoue N, Hirata K, Yokoyama M: Xenogenicmacrophage immunization reducesatherosclerosis in apolipoprotein E knockoutmice. Am J Physiol Cell Physiol 2007;293:C865-C873.
23. Shilova N, Navakouski M, Khasbiullina N,Blixt O, Bovin N: Printed glycan array: antibodiesas probed in undiluted serum and effectsof dilution. Glycoconj J 2012; 29: 87-91.
24. Brouard S, Bouhours D, Sebille F, Menoret S, Soulillou JP, Vanhove B: Induction of anti-Forssman antibodies in the hamster-to-ratxenotransplantation model. Transplantation2000; 69: 1193-1201. (Pubitemid 30217605)
25. Casali P, Schettino EW: Structure and functionof natural antibodies. Curr Top MicrobiolImmunol 1996; 210: 167-179.
26. Parker W: Polyreactive antibodies and theirassociation with xenotransplantation. Xenotransplantation2003; 10: 542-544. (Pubitemid 37309661)
27. Sugii S, Hirota Y: Isolation and hemagglutinatingactivities of bovine immunoglobulinsreactive with melibiose. Jpn J Vet Sci 1990; 52:939-945.
28. Sugii S, Hirota Y: Identification and characterizationof the major carbohydrate-bindingproteins in chicken serum as immunoglobulins.J Vet Med Sci 1993; 55: 125-128.
29. Galili U, Clark MR, Shohet SB, Buehler J, MacherBA: Evolutionary relationship betweenthe natural anti-Gal antibody and the Gal alpha1-3Gal epitope in primates. Proc NatlAcad Sci USA 1987; 84: 1369-1373. (Pubitemid 17027355)
30. Ni Y, Powell R, Turner DD, Tizard I: Specificityand prevalence of natural bovine anti-alphagalactosyl (Gal?1-6Glc or Gal?1-6Gal)antibodies. Clin Diagn Lab Immunol 2000; 7:490-496. (Pubitemid 30263045)
31. von Gunten S, Smith DF, Cummings RD, RiedelS, Miescher S, Schaub A, Hamilton RG, Bochner BS: Intravenous immunoglobulincontains a broad repertoire of anticarbohydrateantibodies that is not restricted to theIgG2 subclass. J Allergy Clin Immunol 2009;123: 1268-1276.
32. Willers JMN, Michel MF: Immunochemistryof the type antigens of Streptococcus faecalis. JGen Microbiol 1966; 43: 375-382.
33. Ota F, Kato H, Fukui K: Immunological studyof cross-reactive polysaccharide antigens(types a, d, and h) of oral Streptococcus sppwith monoclonal antibodies. Infect Immun 1987; 55: 266-268. (Pubitemid 17220400)
34. Bleiweis AS, Krause RM: The cell walls of group D streptococci. 1. The immunochemistry of the type I carbohydrate. J Exp Med 1965;122: 237-249.
35. Hancock LE, Gilmore MS: The capsular polysaccharideof Enterococcus faecalis and its relationshipto other polysaccharides in the cellwall. Proc Natl Acad Sci USA 2002; 99: 1574-1579. (Pubitemid 34136534)
36. Hancock LE, Gilmore MS: Identification ofa highly conserved lipopolysaccharide (LPS)modification operon in Enterococcus faecalis.Adv Exp Med Biol 1997; 418: 1049-1050. (Pubitemid 27438609)
37. Xu Y, Murray BE, Weinstock GM: A cluster of genes involved in polysaccharide biosynthesisfrom Enterococcus faecal is OG1RF. InfectImmun 1998; 66: 4313-4323. (Pubitemid 28402707)
38. Ochsenbein AF, Fehr T, Lutz C, Suter M,Brombacher F, Hengartner H, ZinkernagelRM: Control of early viral and bacterial distributionand disease by natural antibodies. Science 1999; 286: 2156-2159. (Pubitemid 129516290)
39. Skurnik D, Kropec A, Roux D, Theilacker C,Huebner J, Pier GB: Natural antibodies innormal serum inhibit Staphylococcus aureuscapsular vaccine efficacy. Clin Infect Dis2012; 55: 1188-1197.
40. Perez Fontan M, Manez R, Rodriguez-CarmonaA, Peteiro J, Martinez V, Garcia-FalconT, Domenech N: Serum levels of anti-?-galactosyl antibodies predict survival andperitoneal dialysis-related enteric peritonitisrates in patients undergoing renal replacementtherapy. Am J Kidney Dis 2006; 48: 972-982. (Pubitemid 44895376)
41. Arduino RC, Murray BE, Rakita RM: Rolesof antibodies and complement in phagocytickilling of enterococci. Infect Immun 1994; 62:987-993. (Pubitemid 24065586)
42. Kropec A, Theilacker C, Huebner J: Naturallyacquired antibodies against four Enterococcusfaecalis capsular polysaccharides in healthyhuman sera. Clin Diagn Lab Immunol 2005;12: 930-934.
43. Hancock LE: Enterococcus faecalis capsularpolysaccharide serotypes C and D and theircontributions to host innate immune evasion.Infect Immun 2009; 77: 5551-5557.
44. Hamadeh RM, Estabrook MM, Zhou P, JarvisGA, Griffiss JM: Anti-Gal binds to pili of Neisseriameningitidis: the immunoglobulin Aisotype blocks complement-mediated killing.Infect Immun 1995; 63: 4900-4906. (Pubitemid 3004762)